Literature DB >> 920915

Lysosomal enzyme release during cardiopulmonary bypass.

T V Gnanadurai, M A Branthwaite, J F Colbeck, E Welman.   

Abstract

Lysosomal enzyme release occurs during cardiopulmonary bypass in man but the tissues from which these enzymes originate have not been identified. The activity of N-acetyl beta-glucosaminidase in plasma increases to a degree which is proportional to the duration of bypass and this enzyme may therefore be a better marker than beta-glucuronidase of tissue damage caused by cardiopulmonary bypass, as distinct from tissue damage solely to the operative procedure.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 920915     DOI: 10.1111/j.1365-2044.1977.tb10074.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  2 in total

1.  Pharmacological intervention for renal protection during cardiopulmonary bypass.

Authors:  K Hashimoto; K Nomura; M Nakano; T Sasaki; H Kurosawa
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

2.  Endothelin 1 levels in relation to clinical presentation and outcome of Henoch Schonlein purpura.

Authors:  S Fessatou; P Nicolaidou; D Gourgiotis; H Georgouli; K Douros; M Moustaki; A Fretzayas
Journal:  BMC Pediatr       Date:  2008-09-02       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.